[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Peptide Synthesis Market Size, Share & Trends Analysis Report By Product (Equipment, Reagents & Consumables), By Application (Therapeutics, Diagnosis), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030

September 2024 | 100 pages | ID: P0E50864751DEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Pentaerythritol Market Growth & Trends

The global pentaerythritol market size is expected to reach USD 34.61 billion by 2030, and is expected to grow at a CAGR of 43.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Strong shift towards the use of pentaerythritol as a substitute for electrical transformer fluid is expected to drive global pentaerythritol market. Growth of key end-use industries such as construction and automotive particularly in emerging markets of Asia Pacific and Latin America is also expected to impact the market growth positively. Overlapping of formaldehyde and acetaldehyde with other key applications and volatile raw material prices are expected to remain key challenges for market participants.

Paints and coatings emerged as the leading application segment and accounted for 32.39% of the total market volume in 2023. Increasing use of Paints and coatings in the automotive and construction industries is expected to remain a key driving factor for this segment. Paints and coatings is also expected to witness the highest growth rate of 43.2% over the forecast period. Global pentaerythritol demand for plasticizers is expected to grow at an estimated CAGR of 43.2% from 2024 to 2030.

Pentaerythritol Market Report Highlights
  • The global pentaerythritol market size was valued at USD 2.80 billion in 2023 and is expected to grow at a CAGR of 43.2% from 2024 to 2030
  • Asia Pacific was the leading regional market and accounted for 24.5% of the total volume in 2023. Increasing construction spending coupled with a positive outlook on the automotive industry particularly in high growth countries such as China, India, and Indonesia is expected to drive the regional pentaerythritol market. Asia Pacific is also expected to witness the highest growth rate of 43.7% from 2024 to 2030.
  • Europe and North America are mature markets for pentaerythritol and are expected to grow relatively slower than other high growth regions. Recovery of the automotive industry in the U.S. post the economic recession in 2008-09 is expected to drive the North American pentaerythritol market. The growth of the construction industry in Mexico is also expected to complement the regional market growth.
  • The pentaerythritol market in North America accounted for the dominant market share with 40.5% in 2023 owing to the rising demand in the automotive industry
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
  1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

CHAPTER 3. PEPTIDE SYNTHESIS MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
3.4. Peptide Synthesis Market Analysis Tools
  3.4.1. Porter’s Analysis
    3.4.1.1. Bargaining power of the suppliers
    3.4.1.2. Bargaining power of the buyers
    3.4.1.3. Threats of substitution
    3.4.1.4. Threats from new entrants
    3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
    3.4.2.1. Political landscape
    3.4.2.2. Economic and Social landscape
    3.4.2.3. Technological landscape
    3.4.2.4. Environmental landscape
    3.4.2.5. Legal landscape

CHAPTER 4. PEPTIDE SYNTHESIS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS

4.1. Segment Dashboard
4.2. Peptide Synthesis Market Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Equipment
  4.3.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.2. Peptide Synthesizers
    4.3.2.1. Peptide Synthesizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.3. Lyophilizers
    4.3.3.1. Lyophilizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.4. Chromatography Equipment
    4.3.4.1. Chromatography Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.3.5. Others
    4.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Reagents & Consumables
  4.4.1. Reagents & Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.2. Resins
    4.4.2.1. Resins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.3. Amino Acids
    4.4.3.1. Amino Acids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.4. Coupling Reagents
    4.4.4.1. Coupling Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.5. Dyes & Fluroscent Labeling Reagents
    4.4.5.1. Dyes & Fluroscent Labeling reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  4.4.6. Others
    4.4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
  4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. PEPTIDE SYNTHESIS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS

5.1. Segment Dashboard
5.2. Peptide Synthesis Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
5.3. Solid Phase Peptide Synthesis (SPPS)
  5.3.1. Solid Phase Peptide Synthesis (SPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Liquid Phase Peptide Synthesis (LPPS)
  5.4.1. Liquid Phase Peptide Synthesis (LPPS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Hybrid Technology
  5.5.1. Hybrid Technology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. PEPTIDE SYNTHESIS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS

6.1. Segment Dashboard
6.2. Peptide Synthesis Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Therapeutics
  6.3.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.2. Cancer
    6.3.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.3. Metabolic
    6.3.3.1. Metabolic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.4. Cardiovascular Disorder
    6.3.4.1. Cardiovascular Disorder Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.5. Respiratory
    6.3.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.6. GIT (Gastrointestinal Disorders)
    6.3.6.1. GIT (Gastrointestinal Disorders) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.7. Infectious Diseases
    6.3.7.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.8. Pain
    6.3.8.1. Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.9. Dermatology
    6.3.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.10. CNS
    6.3.10.1. CNS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.11. Renal
    6.3.11.1. Renal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.3.12. Others
    6.3.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnosis
  6.4.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Research
  6.5.1. Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. PEPTIDE SYNTHESIS MARKET: END USE ESTIMATES & TREND ANALYSIS

7.1. Segment Dashboard
7.2. Peptide Synthesis Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Pharmaceutical & Biotechnology Companies
  7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Contract Development & Manufacturing Organization/Contract Research Organization
  7.4.1. Contract Development & Manufacturing Organization/Contract Research Organization Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Academic & Research Institutes
  7.5.1. Academic & Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 8. PEPTIDE SYNTHESIS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS

8.1. Peptide Synthesis Market Share, By Region, 2023 & 2030, USD Million
8.2. North America
  8.2.1. North America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.2.2. U.S.
    8.2.2.1. U.S. Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.2.3. Canada
    8.2.3.1. Canada Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.2.4. Mexico
    8.2.4.1. Mexico Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
  8.3.1. Europe Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.2. UK
    8.3.2.1. UK Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.3. Germany
    8.3.3.1. Germany Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.4. France
    8.3.4.1. France Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.5. Italy
    8.3.5.1. Italy Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.6. Spain
    8.3.6.1. Spain Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.7. Denmark
    8.3.7.1. Denmark Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.8. Sweden
    8.3.8.1. Sweden Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.3.9. Norway
    8.3.9.1. Norway Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
  8.4.1. Asia Pacific Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.2. China
    8.4.2.1. China Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.3. Japan
    8.4.3.1. Japan Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.4. India
    8.4.4.1. India Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.5. South Korea
    8.4.5.1. South Korea Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.6. Australia
    8.4.6.1. Australia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.4.7. Thailand
    8.4.7.1. Thailand Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
  8.5.1. Latin America Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.5.2. Brazil
    8.5.2.1. Brazil Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.5.3. Argentina
    8.5.3.1. Argentina Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
  8.6.1. Middle East and Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.2. Saudi Arabia
    8.6.2.1. Saudi Arabia Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.3. UAE
    8.6.3.1. UAE Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.4. South Africa
    8.6.4.1. South Africa Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  8.6.5. Kuwait
    8.6.5.1. Kuwait Peptide Synthesis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
  9.4.1. Thermo Fisher Scientific Inc.
    9.4.1.1. Participant’s Overview
    9.4.1.2. Financial Performance
    9.4.1.3. Product Benchmarking
    9.4.1.4. Recent Developments/Strategic Initiatives
  9.4.2. Merck KGaA
    9.4.2.1. Participant’s Overview
    9.4.2.2. Financial Performance
    9.4.2.3. Product Benchmarking
    9.4.2.4. Recent Developments/Strategic Initiatives
  9.4.3. GenScript
    9.4.3.1. Participant’s Overview
    9.4.3.2. Financial Performance
    9.4.3.3. Product Benchmarking
    9.4.3.4. Recent Developments/Strategic Initiatives
  9.4.4. Bachem Holding AG
    9.4.4.1. Participant’s Overview
    9.4.4.2. Financial Performance
    9.4.4.3. Product Benchmarking
    9.4.4.4. Recent Developments/Strategic Initiatives
  9.4.5. Biotage
    9.4.5.1. Participant’s Overview
    9.4.5.2. Financial Performance
    9.4.5.3. Product Benchmarking
    9.4.5.4. Recent Developments/Strategic Initiatives
  9.4.6. Creative Diagnostics
    9.4.6.1. Participant’s Overview
    9.4.6.2. Financial Performance
    9.4.6.3. Product Benchmarking
    9.4.6.4. Recent Developments/Strategic Initiatives
  9.4.7. PolyPeptide Group
    9.4.7.1. Participant’s Overview
    9.4.7.2. Financial Performance
    9.4.7.3. Product Benchmarking
    9.4.7.4. Recent Developments/Strategic Initiatives
  9.4.8. Syngene International Limited
    9.4.8.1. Participant’s Overview
    9.4.8.2. Financial Performance
    9.4.8.3. Product Benchmarking
    9.4.8.4. Recent Developments/Strategic Initiatives
  9.4.9. Puresynth Research Chemicals Pvt Ltd.
    9.4.9.1. Participant’s Overview
    9.4.9.2. Financial Performance
    9.4.9.3. Product Benchmarking
    9.4.9.4. Recent Developments/Strategic Initiatives
  9.4.10. Lonza
    9.4.10.1. Participant’s Overview
    9.4.10.2. Financial Performance
    9.4.10.3. Product Benchmarking
    9.4.10.4. Recent Developments/Strategic Initiatives


More Publications